Epothilone (Ixabepilone) Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer
Public ClinicalTrials.gov record NCT00082433. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III Study of Novel Epothilone (Ixabepilone) Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer Previously Treated With an Anthracycline and a Taxane
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this clinical research study is to learn if BMS-247550 added to the approved therapy of capecitabine (Xeloda) provides measurable clinical benefits over capecitabine alone in women with metastatic breast cancer. Patients should have previously received an anthracycline and a taxane. The safety of this treatment will also be studied.
Study identification
- NCT ID
- NCT00082433
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,221 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2003 (Type not available)
- Primary completion
- Mar 2008 (Actual)
- Completion
- Mar 2008 (Actual)
- Last update posted
- Nov 2, 2020
2003 – 2008
United States locations
- U.S. sites
- 34
- U.S. states
- 23
- U.S. cities
- 34
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution | Tucson | Arizona | — | — |
| Local Institution | Beverly Hills | California | — | — |
| Local Institution | Corona | California | — | — |
| Local Institution | Hartford | Connecticut | — | — |
| Local Institution | Plantation | Florida | — | — |
| Local Institution | Boise | Idaho | — | — |
| Local Institution | Evanston | Illinois | — | — |
| Local Institution | Iowa City | Iowa | — | — |
| Local Institution | Louisville | Kentucky | — | — |
| Local Institution | Baton Rouge | Louisiana | — | — |
| Local Institution | Bethesda | Maryland | — | — |
| Local Institution | Boston | Massachusetts | — | — |
| Local Institution | Jackson | Mississippi | — | — |
| Local Institution | Columbia | Missouri | — | — |
| Local Institution | Voorhees Township | New Jersey | — | — |
| Local Institution | Albuquerque | New Mexico | — | — |
| Local Institution | Latham | New York | — | — |
| Local Institution | Mineola | New York | — | — |
| Local Institution | New York | New York | — | — |
| Local Institution | The Bronx | New York | — | — |
| Local Institution | Durham | North Carolina | — | — |
| Local Institution | Goldsboro | North Carolina | — | — |
| Local Institution | Hickory | North Carolina | — | — |
| Local Institution | Kinston | North Carolina | — | — |
| Local Institution | Canton | Ohio | — | — |
| Local Institution | Columbus | Ohio | — | — |
| Local Institution | Langhorne | Pennsylvania | — | — |
| Local Institution | Knoxville | Tennessee | — | — |
| Local Institution | Memphis | Tennessee | — | — |
| Local Institution | Dallas | Texas | — | — |
| Local Institution | Charlottesville | Virginia | — | — |
| Local Institution | Norfolk | Virginia | — | — |
| Local Institution | Richmond | Virginia | — | — |
| Local Institution | Marshfield | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 152 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00082433, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 2, 2020 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00082433 live on ClinicalTrials.gov.